Literature DB >> 15557509

Diabetes mellitus in midlife and the risk of dementia three decades later.

M Schnaider Beeri1, U Goldbourt, J M Silverman, S Noy, J Schmeidler, R Ravona-Springer, A Sverdlick, M Davidson.   

Abstract

OBJECTIVE: To examine the association between diabetes in midlife (1963-1968) and dementia more than three decades later (1999-2001).
METHODS: The authors characterized dementia using standard methods for 1,892 participants among 2,606 survivors of 10,059 participants in the Israeli Ischemic Heart Disease study, a longitudinal investigation of the incidence of and risk factors for cardiovascular disease among Jewish male civil servants in Israel. Face to face interviews were conducted with the 652 subjects identified as possibly demented by the Modified Telephone Interview for Cognitive Status. Logistic regression analysis was performed to assess the association of diabetes with dementia controlling for sociodemographic and cardiovascular variables compared to those with no cognitive impairment.
RESULTS: Of 1,892 assessed subjects (mean age 82 at assessment), 309 (16.3%) had dementia. Diabetic subjects had significantly more dementia than non-diabetic subjects (chi2 = 7.54, df = 1, p = 0.006, OR 2.83 [95% CI = 1.40 to 5.71]). Those who survived to the time of this study were younger and healthier than those who died.
CONCLUSIONS: Evidence for diabetes as a risk factor for dementia was found, similar to other epidemiologic studies. In contrast to the earlier studies, however, the authors linked diabetes in midlife to dementia more than three decades later in the very old survivors of a large male cohort.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557509     DOI: 10.1212/01.wnl.0000144278.79488.dd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  95 in total

1.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.

Authors:  Michal Schnaider Beeri; Erin Moshier; James Schmeidler; James Godbold; Jaime Uribarri; Sarah Reddy; Mary Sano; Hillel T Grossman; Weijing Cai; Helen Vlassara; Jeremy M Silverman
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

2.  Cognitive prescriptions.

Authors:  David E Vance; Greg Eagerton; Brenna Harnish; Peggy McKie; Pariya L Fazeli
Journal:  J Gerontol Nurs       Date:  2010-12-22       Impact factor: 1.254

3.  Midlife cardiovascular risk impacts executive function: Framingham offspring study.

Authors:  Arvind Nishtala; Sarah R Preis; Alexa Beiser; Sherral Devine; Lisa Hankee; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

4.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

Review 5.  The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.

Authors:  Zi-Xuan Wang; Lan Tan; Jinyuan Liu; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

6.  Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.

Authors:  Kamile Silay; Ahmet Yalcin; Sema Akinci; Fatma Gul Gursoy; Didem Sener Dede
Journal:  Wien Klin Wochenschr       Date:  2017-09-01       Impact factor: 1.704

7.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

8.  Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.

Authors:  Yaomin Chen; Kun Zhou; Ruishan Wang; Yun Liu; Young-Don Kwak; Tao Ma; Robert C Thompson; Yongbo Zhao; Layton Smith; Laura Gasparini; Zhijun Luo; Huaxi Xu; Francesca-Fang Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

9.  Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia.

Authors:  Danielle Wilson; Ruth Peters; Karen Ritchie; Craig W Ritchie
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

10.  An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype.

Authors:  Nina S Levy; Moshe Vardi; Shany Blum; Rachel Miller-Lotan; Yefim Afinbinder; Patricia A Cleary; Andrew D Paterson; Bhupinder Bharaj; Janet K Snell-Bergeon; Marian J Rewers; Orit Lache; Andrew P Levy
Journal:  Clin Chem Lab Med       Date:  2013-08       Impact factor: 3.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.